Algeria vs Solomon Islands: Previously treated cases tested for RR-/MDR-TB
Algeria
8.2%
in 2023
Solomon Islands
9.1%
in 2024
Algeria rank
168th
Solomon Islands rank
167th
Previously treated cases tested for RR-/MDR-TB over time
- Algeria
- Solomon Islands
How they compare
Solomon Islands currently reports 9.1% against 8.2% in Algeria, a difference of 0.9%.
That makes Solomon Islands's figure about 1.1 times Algeria's.
The two have swapped places 5 times across 9 shared years of data; in 2014 it was Algeria ahead.
Algeria ranks 168th and Solomon Islands ranks 167th of 180 countries.
Across the 2 decades both report, Algeria averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Algeria | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.4% | 21.7% | 16.8% | Algeria |
| 2020s | 20.7% | 39.0% | 18.3% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Algeria or Solomon Islands?
- Solomon Islands, at 9.1% against 8.2% in Algeria as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Algeria and Solomon Islands?
- 0.9%, with Solomon Islands ahead.
- How many years of comparable data are there for Algeria and Solomon Islands?
- 9 years are reported by both, from 2014 to 2023.
- How do Algeria and Solomon Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Algeria ranks 168th and Solomon Islands ranks 167th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.